L’hôpital Lariboisière est un hôpital de l'Assistance Publique - Hôpitaux de Paris situé 2 rue Ambroise-Paré dans le 10ᵉ arrondissement de Paris. Il a été construit au XIXᵉ siècle selon les théories hygiénistes et sur un type pavillonnaire. Il a ouvert ses portes en 1854.

During the past decade, AP-HP Lariboisière conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AP-HP Lariboisière" #1 sponsor was "Centre Hospitalier Universitaire de Nice" with 1 trials, followed by "Societe Francaise de Rhumatologie" with 1 trials sponsored, "Tourcoing Hospital" with 1 trials sponsored, "University Hospital, Clermont-Ferrand" with 1 trials sponsored and "University Hospital, Grenoble" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AP-HP Lariboisière" #1 collaborator was "Bordeaux PharmacoEpi" with 1 trials as a collaborator and "Institut ANALGESIA" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "AP-HP Lariboisière" are "Chronic Pain" (1 trials), "Inflammatory Rheumatism" (1 trials), "Mild Traumatic Brain Injury" (1 trials), "Osteomyelitis - Foot" (1 trials) and "Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "AP-HP Lariboisière" in a lesser frequency.

Most popular intervention types in "AP-HP Lariboisière" are "Device" (1 trials), "Drug" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Reduction in the duration of antibiotic therapy 3 weeks or 6 weeks" (1 trials), "Transcranial Doppler (TCD)" (1 trials), "e-DOL" (1 trials) and "no intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "AP-HP Lariboisière" are 5 trials for "All" genders.

Currently, there are NaN active trials in "AP-HP Lariboisière". 1 are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in AP-HP Lariboisière, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AP-HP Lariboisière, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".